These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 25812627)

  • 21. Prenatal exposure to perfluoroalkyl substances modulates neonatal serum phospholipids, increasing risk of type 1 diabetes.
    McGlinchey A; Sinioja T; Lamichhane S; Sen P; Bodin J; Siljander H; Dickens AM; Geng D; Carlsson C; Duberg D; Ilonen J; Virtanen SM; Dirven H; Berntsen HF; Zimmer K; Nygaard UC; Orešič M; Knip M; Hyötyläinen T
    Environ Int; 2020 Oct; 143():105935. PubMed ID: 32634666
    [TBL] [Abstract][Full Text] [Related]  

  • 22. What Happens In Utero Does Not Stay In Utero: a Review of Evidence for Prenatal Epigenetic Programming by Per- and Polyfluoroalkyl Substances (PFAS) in Infants, Children, and Adolescents.
    Perng W; Nakiwala D; Goodrich JM
    Curr Environ Health Rep; 2023 Mar; 10(1):35-44. PubMed ID: 36414885
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prenatal exposure to poly- and perfluoroalkyl substances and the incidence of asthma in early childhood.
    Zell-Baran LM; Venter C; Dabelea D; Norris JM; Glueck DH; Adgate JL; Brown JM; Calafat AM; Pickett-Nairne K; Starling AP
    Environ Res; 2023 Dec; 239(Pt 1):117311. PubMed ID: 37805178
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prenatal Exposure to Perfluoroalkyl Substances Associated With Increased Susceptibility to Liver Injury in Children.
    Stratakis N; V Conti D; Jin R; Margetaki K; Valvi D; Siskos AP; Maitre L; Garcia E; Varo N; Zhao Y; Roumeliotaki T; Vafeiadi M; Urquiza J; Fernández-Barrés S; Heude B; Basagana X; Casas M; Fossati S; Gražulevičienė R; Andrušaitytė S; Uppal K; McEachan RRC; Papadopoulou E; Robinson O; Haug LS; Wright J; Vos MB; Keun HC; Vrijheid M; Berhane KT; McConnell R; Chatzi L
    Hepatology; 2020 Nov; 72(5):1758-1770. PubMed ID: 32738061
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Associations between concentrations of perfluoroalkyl substances in human plasma and maternal, infant, and home characteristics in Winnipeg, Canada.
    Workman CE; Becker AB; Azad MB; Moraes TJ; Mandhane PJ; Turvey SE; Subbarao P; Brook JR; Sears MR; Wong CS
    Environ Pollut; 2019 Jun; 249():758-766. PubMed ID: 30933773
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Exposure to Perfluoroalkyl Substances During Pregnancy and Fetal BDNF Level: A Prospective Cohort Study.
    Yu G; Luo F; Nian M; Li S; Liu B; Feng L; Zhang J
    Front Endocrinol (Lausanne); 2021; 12():653095. PubMed ID: 34140927
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In utero exposure to poly- and perfluoroalkyl substances and children respiratory health in the three first years of life.
    Philippat C; Coiffier O; Lyon-Caen S; Boudier A; Jovanovic N; Quentin J; Gioria Y; Haug LS; Thomsen C; Bayat S; Slama R; Siroux V
    Environ Res; 2023 Oct; 234():116544. PubMed ID: 37406719
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prenatal exposure to perfluorobutanesulfonic acid and childhood adiposity: A prospective birth cohort study in Shanghai, China.
    Chen Q; Zhang X; Zhao Y; Lu W; Wu J; Zhao S; Zhang J; Huang L
    Chemosphere; 2019 Jul; 226():17-23. PubMed ID: 30908964
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Perfluoroalkyl and polyfluoroalkyl substances and indicators of immune function in children aged 12-19 y: National Health and Nutrition Examination Survey.
    Stein CR; McGovern KJ; Pajak AM; Maglione PJ; Wolff MS
    Pediatr Res; 2016 Feb; 79(2):348-57. PubMed ID: 26492286
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of prenatal perfluorinated chemicals exposures on pediatric atopy.
    Wang IJ; Hsieh WS; Chen CY; Fletcher T; Lien GW; Chiang HL; Chiang CF; Wu TN; Chen PC
    Environ Res; 2011 Aug; 111(6):785-91. PubMed ID: 21601844
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prenatal exposure to phthalates, bisphenol A and perfluoroalkyl substances and cord blood levels of IgE, TSLP and IL-33.
    Ashley-Martin J; Dodds L; Levy AR; Platt RW; Marshall JS; Arbuckle TE
    Environ Res; 2015 Jul; 140():360-8. PubMed ID: 25913155
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term effects of prenatal exposure to perfluoroalkyl substances on female reproduction.
    Kristensen SL; Ramlau-Hansen CH; Ernst E; Olsen SF; Bonde JP; Vested A; Halldorsson TI; Becher G; Haug LS; Toft G
    Hum Reprod; 2013 Dec; 28(12):3337-48. PubMed ID: 24129614
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Maternal exposure to specific perfluoroalkyl substances is associated with increasing blood glucose in pregnant women.
    Uppal JS; Zheng Q; Le XC
    J Environ Sci (China); 2018 Jul; 69():1-2. PubMed ID: 29941244
    [No Abstract]   [Full Text] [Related]  

  • 34. Bias from conditioning on live birth in pregnancy cohorts: an illustration based on neurodevelopment in children after prenatal exposure to organic pollutants.
    Liew Z; Olsen J; Cui X; Ritz B; Arah OA
    Int J Epidemiol; 2015 Feb; 44(1):345-54. PubMed ID: 25604449
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Early life exposure to per- and polyfluoroalkyl substances (PFAS) and latent health outcomes: A review including the placenta as a target tissue and possible driver of peri- and postnatal effects.
    Blake BE; Fenton SE
    Toxicology; 2020 Oct; 443():152565. PubMed ID: 32861749
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum Perfluoroalkyl Substances, Vaccine Responses, and Morbidity in a Cohort of Guinea-Bissau Children.
    Timmermann CAG; Jensen KJ; Nielsen F; Budtz-Jørgensen E; van der Klis F; Benn CS; Grandjean P; Fisker AB
    Environ Health Perspect; 2020 Aug; 128(8):87002. PubMed ID: 32772733
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prenatal exposure to perfluoroalkyl and polyfluoroalkyl substances affects leukocyte telomere length in female newborns.
    Liu H; Chen Q; Lei L; Zhou W; Huang L; Zhang J; Chen D
    Environ Pollut; 2018 Apr; 235():446-452. PubMed ID: 29310088
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prenatal Exposure to Per- and Polyfluoroalkyl Substances (PFASs) and Association between the Placental Transfer Efficiencies and Dissociation Constant of Serum Proteins-PFAS Complexes.
    Gao K; Zhuang T; Liu X; Fu J; Zhang J; Fu J; Wang L; Zhang A; Liang Y; Song M; Jiang G
    Environ Sci Technol; 2019 Jun; 53(11):6529-6538. PubMed ID: 31099564
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Perfluoroalkyl substances exposure and immunity, allergic response, infection, and asthma in children: review of epidemiologic studies.
    von Holst H; Nayak P; Dembek Z; Buehler S; Echeverria D; Fallacara D; John L
    Heliyon; 2021 Oct; 7(10):e08160. PubMed ID: 34712855
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Newborn metabolomic signatures of maternal per- and polyfluoroalkyl substance exposure and reduced length of gestation.
    Taibl KR; Dunlop AL; Barr DB; Li YY; Eick SM; Kannan K; Ryan PB; Schroder M; Rushing B; Fennell T; Chang CJ; Tan Y; Marsit CJ; Jones DP; Liang D
    Nat Commun; 2023 May; 14(1):3120. PubMed ID: 37253729
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.